mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |